Form S-1/A Parabilis Medicines,
Tweet
Share
E-mailhttp://archive.fast-edgar.com/20260609/A422TG2EZZ2RPZZ222TC2ZYRHRBD4Z22N282
Filed on: June 9, 2026
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Takeda psoriasis drug shows skin clearance in Phase 3 trials
- Summit Therapeutics sells antibiotic asset ridinilazole for up to $105M
- Eightco Holdings reports $406M in total treasury assets
Create E-mail Alert Related Categories
SEC FilingsRelated Entities
S1Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
